Two Sigma Advisers’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-241,600
Closed -$2.49M 2700
2023
Q3
$2.49M Buy
241,600
+21,700
+10% +$206K 0.01% 1078
2023
Q2
$1.81M Buy
219,900
+103,400
+89% +$619K ﹤0.01% 1255
2023
Q1
$651K Sell
116,500
-61,000
-34% -$349K ﹤0.01% 1829
2022
Q4
$879K Sell
177,500
-152,514
-46% -$628K ﹤0.01% 1631
2022
Q3
$1.58M Buy
330,014
+77,814
+31% +$334K ﹤0.01% 1289
2022
Q2
$648K Sell
252,200
-186,000
-42% -$698K ﹤0.01% 1805
2022
Q1
$2.52M Buy
+438,200
New +$3.93M 0.01% 1119
2018
Q4
Sell
-5,300
Closed -$430K 2498
2018
Q3
$430K Buy
+5,300
New +$388K ﹤0.01% 1853

Other funds holding TRHC

Two Sigma Advisers's TRHC Position: Q4 2023 in Review

Two Sigma Advisers sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 241,600 shares — an estimated $2.49M sold.

Two Sigma Advisers first reported a position in TRHC in Q3 2018 and held it in 8 quarters. The position peaked at $2.52M in Q1 2022. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.

  • Two Sigma Advisers reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 241,600 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $2.49M.
  • Two Sigma Advisers first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • Two Sigma Advisers's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $2.52M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.

Based on Two Sigma Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.